Women’s Health Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Women's Health Market
The Women's Health Market size was valued at USD 35.02 billion in 2019 and is projected to reach USD 41.05 billion by 2027, exhibiting a CAGR of 3.2% during the forecast period of 2024-2032.
The COVID-19 pandemic disrupted the women’s health marketplace significantly. Lockdowns and healthcare resource reallocation behind schedule non-urgent gynecological consultations, contraceptive get entry to, and optional approaches. Mental fitness issues, along with tension and melancholy, rose sharply among women because of extended caregiving obligations and process losses. However, telemedicine emerged as a crucial opportunity, allowing continued access to healthcare services. The pandemic underscored the significance of sturdy healthcare infrastructure and multiplied focus of girls-precise fitness desires, leading to renewed consciousness on innovation and investment on this quarter post-pandemic.
The integration of digital health answers, along with wearable gadgets, mobile apps, and AI-pushed platforms, is remodeling the women’s health market. These innovations focus on personalized care, menstrual cycle tracking, fertility management, and maternal fitness monitoring. For instance, femtech programs like length-monitoring apps or fertility monitors are empowering girls to make informed health selections. This trend is fueled by way of developing telephone penetration, expanded fitness consciousness, and demand for handy, statistics-pushed healthcare answers. The virtual fitness boom is enhancing accessibility and allowing ladies to take proactive manage of their fitness.
Growing recognition of women’s health issues, supported by government initiatives, is a chief driving element within the marketplace. Governments and companies international are launching campaigns addressing critical regions like reproductive health, menstrual hygiene, and breast cancer. Subsidies and applications selling lower priced get entry to to contraceptives and maternal care are boosting demand. Additionally, worldwide advocacy for gender-particular health desires is encouraging investments in research and innovation. This growing attention on ladies’s well-being is creating possibilities for the improvement and adoption of recent services and products tailor-made to girls’s fitness.
Comprehensive Analysis of Women's Health Market
The Women's Health Market growth is rising at an exponential rate due to its marketplace segmentation. This market expansion correctly affords a detailed local assessments thinking about the dominant supply and call for forces that effect the enterprise. These segmentations are methodically segregated By distribution channel, by application. By Application Include Contraceptives, Osteoporosis, Menopause, Infertility, Others. By Distribution Channel include Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
The North America region lead the Women's Health Market share by benefitting a market size of USD 18.00 billion The high adoption rate of women’s health products in the U.S. and Canada for improved health of women, huge spending on the health of female populations, and rising prevalence of diseases in women are some of the major factors favoring the dominance of the region.
The top players in the market play a crucial role in the industry assuring market growth and setting market standards. These players include, Google LLC (Alphabet, Inc.), Magic Leap, Inc., ReWalk Robotics, SAMSUNG, B-Temia, Panasonic Holdings Corporation, NVIDIA Corporation, Microsoft, Ekso Bionics, Vuzix,these market players provide a level-playing competitive landscape.
June 2021 Organon penetrated as the most effective global girls’s fitness organization at New York stock excahange. The agency is dedicated to addressing the demanding situations in girls’s health desires, that specialize in reproductive fitness and health specific health situations
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2016-2027
Base Year 2019
Forecast Period 2020-2027
Historical Period 2016-2018
Unit Value (USD Billion)
Segmentation Application; Distribution Channel and Geography
By Application
Contraceptives
Osteoporosis
Menopause
Infertility
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography
North America
By Application
By Distribution Channel
By Country
USA (By Application)
Canada (By Application)
Europe
By Application
By Distribution Channel
By Country/Sub-region
The UK (By Application)
Germany (By Application)
France (By Application)
Italy (By Application)
Spain (By Application)
Scandinavia (By Application)
Rest of Europe (By Application)
Asia Pacific
By Application
By Distribution Channel
By Country/Sub-region
Japan (By Application)
China (By Application)
India (By Application)
Australia (By Application)
Southeast Asia (By Application)
Rest of Asia Pacific (By Application)
Latin America
By Application
By Distribution Channel
By Country/Sub-region
Brazil (By Application)
Mexico (By Application)
Rest of Latin America (By Application)
The Middle East & Africa
By Application
By Distribution Channel
By Country/Sub-region
GCC (By Application)
South Africa (By Application)
Rest of the MEA (By Application)
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Prevalence of Women Related Disorders, By Key Countries/Region
- 4.2. New Product Launches
- 4.3. Key Mergers, Acquisition, and Partnerships
- 4.4. Key Industry Trends
- 4.5. Impact of COVID-19 on Women's Health Market
- 5. Global Women's Health Market Analysis, Insights and Forecast, 2016-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Application
- 5.2.1. Contraceptives
- 5.2.2. Osteoporosis
- 5.2.3. Menopause
- 5.2.4. Infertility
- 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast – By Distribution Channel
- 5.3.1. Hospital Pharmacies
- 5.3.2. Retail Pharmacies
- 5.3.3. Online Pharmacies
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
- 6. North America Women's Health Market Analysis, Insights and Forecast, 2016-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis – By Application
- 6.2.1. Contraceptives
- 6.2.2. Osteoporosis
- 6.2.3. Menopause
- 6.2.4. Infertility
- 6.2.5. Others
- 6.3. Market Analysis – By Distribution Channel
- 6.3.1. Hospital Pharmacies
- 6.3.2. Retail Pharmacies
- 6.3.3. Online Pharmacies
- 6.4. Market Analysis – By Country
- 6.4.1. U.S.
- 6.4.1.1. By Application
- 6.4.2. Canada
- 6.4.2.1. By Application
- 7. Europe Women's Health Market Analysis, Insights and Forecast, 2016-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis – By Application
- 7.2.1. Contraceptives
- 7.2.2. Osteoporosis
- 7.2.3. Menopause
- 7.2.4. Infertility
- 7.2.5. Others
- 7.3. Market Analysis – By Distribution Channel
- 7.3.1. Hospital Pharmacies
- 7.3.2. Retail Pharmacies
- 7.3.3. Online Pharmacies
- 7.4. Market Analysis – By Country/Sub-region
- 7.4.1. U.K.
- 7.4.1.1. By Application
- 7.4.2. Germany
- 7.4.2.1. By Application
- 7.4.3. France
- 7.4.3.1. By Application
- 7.4.4. Spain
- 7.4.4.1. By Application
- 7.4.5. Italy
- 7.4.5.1. By Application
- 7.4.6. Scandinavia
- 7.4.6.1. By Application
- 7.4.7. Rest of Europe
- 7.4.7.1. By Application
- 8. Asia Pacific Women's Health Market Analysis, Insights and Forecast, 2016-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis – By Application
- 8.2.1. Contraceptives
- 8.2.2. Osteoporosis
- 8.2.3. Menopause
- 8.2.4. Infertility
- 8.2.5. Others
- 8.3. Market Analysis – By Distribution Channel
- 8.3.1. Hospital Pharmacies
- 8.3.2. Retail Pharmacies
- 8.3.3. Online Pharmacies
- 8.4. Market Analysis – By Country/Sub-region
- 8.4.1. Japan
- 8.4.1.1. By Application
- 8.4.2. China
- 8.4.2.1. By Application
- 8.4.3. India
- 8.4.3.1. By Application
- 8.4.4. Australia
- 8.4.4.1. By Application
- 8.4.5. Southeast Asia
- 8.4.5.1. By Application
- 8.4.6. Rest of Asia Pacific
- 8.4.6.1. By Application
- 9. Latin America Women's Health Market Analysis, Insights and Forecast, 2016-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis – By Application
- 9.2.1. Contraceptives
- 9.2.2. Osteoporosis
- 9.2.3. Menopause
- 9.2.4. Infertility
- 9.2.5. Others
- 9.3. Market Analysis – By Distribution Channel
- 9.3.1. Hospital Pharmacies
- 9.3.2. Retail Pharmacies
- 9.3.3. Online Pharmacies
- 9.4. Market Analysis – By Country/Sub-region
- 9.4.1. Brazil
- 9.4.1.1. By Application
- 9.4.2. Mexico
- 9.4.2.1. By Application
- 9.4.3. Rest of Latin America
- 9.4.3.1. By Application
- 10. Middle East & Africa Women's Health Market Analysis, Insights and Forecast, 2016-2027
- 10.1. Key Findings / Summary
- 10.2. Market Analysis – By Application
- 10.2.1. Contraceptives
- 10.2.2. Osteoporosis
- 10.2.3. Menopause
- 10.2.4. Infertility
- 10.2.5. Others
- 10.3. Market Analysis – By Distribution Channel
- 10.3.1. Hospital Pharmacies
- 10.3.2. Retail Pharmacies
- 10.3.3. Online Pharmacies
- 10.4. Market Analysis – By Country/Sub-region
- 10.4.1. GCC Countries
- 10.4.1.1. By Application
- 10.4.2. South Africa
- 10.4.2.1. By Application
- 10.4.3. Rest of Middle East & Africa
- 10.4.3.1. By Application
- 11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2019)
- 11.3. Competition Dashboard
- 11.4. Comparative Analysis – Major Players
- 11.5. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (based on availability))
- 11.5.1. Bayer AG
- 11.5.1.1. Overview,
- 11.5.1.2. Products & Services,
- 11.5.1.3. SWOT Analysis,
- 11.5.1.4. Recent Developments,
- 11.5.1.5. Strategies,
- 11.5.1.6. Financials (based on availability)
- 11.5.2. Pfizer Inc.
- 11.5.2.1. Overview,
- 11.5.2.2. Products & Services,
- 11.5.2.3. SWOT Analysis,
- 11.5.2.4. Recent Developments,
- 11.5.2.5. Strategies,
- 11.5.2.6. Financials (based on availability)
- 11.5.3. Amgen Inc.
- 11.5.3.1. Overview,
- 11.5.3.2. Products & Services,
- 11.5.3.3. SWOT Analysis,
- 11.5.3.4. Recent Developments,
- 11.5.3.5. Strategies,
- 11.5.3.6. Financials (based on availability)
- 11.5.4. Novartis AG
- 11.5.4.1. Overview,
- 11.5.4.2. Products & Services,
- 11.5.4.3. SWOT Analysis,
- 11.5.4.4. Recent Developments,
- 11.5.4.5. Strategies,
- 11.5.4.6. Financials (based on availability)
- 11.5.5. Merck & Co., Inc.
- 11.5.5.1. Overview,
- 11.5.5.2. Products & Services,
- 11.5.5.3. SWOT Analysis,
- 11.5.5.4. Recent Developments,
- 11.5.5.5. Strategies,
- 11.5.5.6. Financials (based on availability)
- 11.5.6. Eli Lilly and Company
- 11.5.6.1. Overview,
- 11.5.6.2. Products & Services,
- 11.5.6.3. SWOT Analysis,
- 11.5.6.4. Recent Developments,
- 11.5.6.5. Strategies,
- 11.5.6.6. Financials (based on availability)
- 11.5.7. LUPIN
- 11.5.7.1. Overview,
- 11.5.7.2. Products & Services,
- 11.5.7.3. SWOT Analysis,
- 11.5.7.4. Recent Developments,
- 11.5.7.5. Strategies,
- 11.5.7.6. Financials (based on availability)
- 11.5.8. AstraZeneca
- 11.5.8.1. Overview,
- 11.5.8.2. Products & Services,
- 11.5.8.3. SWOT Analysis,
- 11.5.8.4. Recent Developments,
- 11.5.8.5. Strategies,
- 11.5.8.6. Financials (based on availability)
- 11.5.9. Other Players
- 11.5.9.1. Overview,
- 11.5.9.2. Products & Services,
- 11.5.9.3. SWOT Analysis,
- 11.5.9.4. Recent Developments,
- 11.5.9.5. Strategies,
- 11.5.9.6. Financials (based on availability)
- 12. Strategic Recommendations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook